MedTrace Logo

Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors

NCT03565159 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2023-11-24

No results posted yet for this study

Summary

The VACIRiSS trial is a phase-IV, multi-centre placebo controlled randomised trial of conjugate pneumococcal vaccine in adult sepsis survivors.

Conditions

Interventions

BIOLOGICAL

Prevenar 13

Pneumococcal polysaccharide conjugate vaccine

OTHER

Sodium Chloride 0.9%

Placebo

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Guy's and St Thomas' NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Manu Shankar-Hari, PhD · Guy's and St Thomas' NHS Foundation Trust and King's College London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-02
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03565159 on ClinicalTrials.gov